| 英文别名 |
(1S)-1-(1,3-Benzodioxol-5-yl)ethanamine;(+)-Paredrine;CHEMBL1927024;(+)-p-Hydroxyamphetamine;S(+)-4-hydroxyamphetamine;(S)-p-hydroxyamphetamine;SureCN256809;(S)-1-(benzo[1,3]dioxol-5-yl)ethylamine;(+)-4-Hydroxyamphetamine;(S)-(-)-1-(4'-hydroxy)phenyl-2-propanamine;(+)-Paredrinex;d-p-Hydroxyamphetamine;AC1LD8EI;(+)-Hydroxyamphetamine;(S)-(-)-1-(benzo[d][1,3]dioxol-5-yl)ethanamine;D-4-Hydroxyamphetamine;(S)-(-)-BDEA;(S)-1-(4-hydroxyphenyl)-2-aminopropane;(S)-1-(Benzo[d][1,3]dioxol-5-yl)ethanamine;(S)-1-(4-hydroxyphen;(1S)-1-(2H-1,3-benzodioxol-5-yl)ethan-1-amine;AS-77499;AMY202003220;SCHEMBL16325098;CS-0158253;210488-52-1;MFCD08057359;(1S)-1-(1,3-dioxaindan-5-yl)ethan-1-amine;1,3-Benzodioxole-5-methanamine, .alpha.-methyl-, (.alpha.S)-;(S)-1-(benzo[d][1,3]dioxol-5-yl)ethylamine;EN300-87774;AKOS024258761 |